Jessica Thomes Pepin, MD
Gynecologic Oncology · Woodbury, MNNPI 1013159029
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $555 of the $841 with a category attached, or 66.0%. Astrazeneca UK Limited accounts for 66.0% of it on its own, with 5 other manufacturers making up the rest. 2023 is the largest year on record at $644, more than ten times the $58 reported in 2020. That places this record below the midpoint for gynecologic oncology clinicians in MN, where the typical reported total is $783.
Across 6 payments — averaging $140.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$555
- AbbVie$120
- Novocure Inc.$58
- AstraZeneca$53
- Eisai Inc.$36
- Bayer$19
Across 210 payments — averaging $13,084 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure Inc.$1.6M
- AbbVie$560K
- Genentech, Inc.$284K
- Genmab U.S., Inc.$173K
- AstraZeneca$78K
- Merck$63K
- plus $37K from 4 others
What the payments were for
- Consulting fees$55566%
- Grants$12014%
- Food & beverage$16620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 1 | $555 |
| AbbVie | 1 | $120 |
| Novocure Inc. | 1 | $58 |
| AstraZeneca | 1 | $53 |
| Eisai Inc. | 1 | $36 |
| Bayer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$841 in reported general payments places this provider in the 50th percentile of 39 gynecologic oncology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LynparzaOlaparib | 13 | $205,570 |
| EliquisApixaban | 12 | $6,850 |
| Letrozole | 24 | $746 |
| Potassium Citrate ErPotassium Citrate | 12 | $417 |
| Gabapentin | 12 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaLynparza | $53 | $205,57013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 39 gynecologic oncology providers in Minnesota.
Other gynecologic oncology in Woodbury
- Angela ZiebarthWoodbury$515
- Levi DownsSt Louis Park$108K
- Jamie Bakkum-GamezRochester$51K
- Lori WeinbergCoon Rapids$47K
- Ebrahim VersiEden Prairie$32K
- Britt EricksonMinneapolis$28K
- William ClibyRochester$15K
- Melissa GellerMinneapolis$14K
- Emily PrendergastMinneapolis$10K
- Carrie LangstraatRochester$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.